Diamond Clinic Sp. z o.o.
Verified siteFast reply
Cracow, Poland
Rare diseases
Investigational molecules
Locations
A plain-language summary of the goals, design and what participants do
This clinical trial is focused on studying Alzheimer's Disease, a condition that affects memory and thinking skills. The study will evaluate a new treatment called LY3372689, which is taken as a tablet. The purpose of the study is to assess the safety, tolerability, and effectiveness of LY3372689 in people with early symptoms of Alzheimer's Disease. Participants will be randomly assigned to receive either the new treatment or a placebo, which looks like the treatment but does not contain the active substance.
Another part of the study involves using a substance called Flortaucipir, which is given as an injection. This substance helps in imaging techniques to detect certain changes in the brain associated with Alzheimer's Disease. The study will last for a period of time, during which participants will have regular check-ups and assessments to monitor their condition and any changes in their symptoms.
The study aims to understand how LY3372689 affects the progression of Alzheimer's Disease by comparing it to the placebo. Participants will be closely monitored by healthcare professionals throughout the study to ensure their safety and to gather important information about the treatment's impact on their health and well-being.
The trial runs in 5 steps – from screening to follow-up. Each step says what happens and what the team monitors.
5 criteria
6 criteria
Tell us about your condition – we search every trial in Europe and connect you with the right site.
We usually reply within a few days
All sites with verified contact details – recruitment status may not be available; ask directly
Cracow, Poland
Poznan, Poland
Gdansk, Poland
Where you can join this trial
Countries are shaded by recruitment status. Click a recruiting country to ask about joining there.
Not recruitingJoining a clinical trial can seem overwhelming. We guide you step by step, so you know exactly what to expect and how we support you through the process.
sourced from the EU Clinical Trials Register and site verification
Want to learn more about this trial or check if you can participate?
Tell us about your condition – we search every trial in Europe and connect you with the right site.